Evaluation of the Coping Long Term With Active Suicide Program
CLASP
1 other identifier
interventional
224
1 country
1
Brief Summary
The purpose of this study is to evaluate the utility of the Coping Long Term with Active Suicide Program (CLASP) for reducing suicidal behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 5, 2014
CompletedFirst Posted
Study publicly available on registry
December 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedJune 7, 2021
June 1, 2021
6.3 years
December 5, 2014
June 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
A composite composed of the number of participants with either a suicide attempt or death by suicide
As assessed by both the Columbia Suicide Severity Rating Scale and record review
52 weeks following discharge from hospital
Study Arms (2)
SAFE
ACTIVE COMPARATORSafety Assessment and Follow-up Evaluation Protocol
CLASP
EXPERIMENTALCoping Long Term with Active Suicide Program Protocol
Interventions
Eligibility Criteria
You may qualify if:
- Current patient at Butler Hospital
- Suicide attempt or suicidal ideation with intent to make a suicide attempt within 48 hours of hospitalization as indicated on the hospital chart and confirmed by administration of the C-SSRS
- Age \> 18 years
- Have a reliable telephone
- Ability to speak, read, and understand English well to complete the procedures of the study
You may not qualify if:
- Current psychotic symptoms severe enough to impair study participation
- Participation in a treatment program with established efficacy in preventing suicidal behavior
- Cognitive impairment which would interfere with adequate participation in the project (MMSE\< 20).
- \. Currently in state custody or pending legal action 5. Already enrolled current or previous CLASP trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Butler Hospitallead
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Psychosocial Research
Study Record Dates
First Submitted
December 5, 2014
First Posted
December 10, 2014
Study Start
December 1, 2014
Primary Completion
March 31, 2021
Study Completion
March 31, 2021
Last Updated
June 7, 2021
Record last verified: 2021-06